Abhishek Kumar¹*, Shubham Tripathi² and Ram Babu Tripathi³

¹Faculty of Pharmaceutical Sciences, Rama University Kanpur, Uttar Pradesh, India
²Geeta Pharmacy College, Lucknow, Uttar Pradesh, India
³Amity Institute of Pharmacy, Amity University Gwalior, Madhya Pradesh, India

*Corresponding Author: Abhishek Kumar, Faculty of Pharmaceutical Sciences, Rama University Kanpur, Uttar Pradesh, India.

Received: March 06, 2023; Published: March 27, 2023

Abstract

The advancements in big pharma's use of related drug discovery research, synthetic and medicinal chemistry, and other fields during the past few decades are discussed. More enormous societal transformations, such as the computer, the internet, and globalisation, have influenced these. Thoughts on the future of medicinal chemistry are also covered, including the potential of outsourcing and sharing the costs and risks of drug discovery. Algorithm utilisation in data analysis and medication creation, as well as the ongoing effects of big data and easy access to mighty computational power, are also discussed. The communication styles of the upcoming generation of medicinal chemists will be influenced by social media, the effects of being continuously linked, and data.

 Keywords: Medicinal Chemistry; Drug Discovery; Instrumental Technology; Pharmaceutical Science; Computer Application

References

1. JG Lombardino and J A Lowe. “The role of the medicinal chemist in drug discovery - Then and now”. Nature Reviews Drug Discovery 10 (2004): 853-862.
2. DG Brown and J Boström. “Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?”. Journal of Medicinal Chemistry 10 (2016): 4443-4458.
3. IB Campbell., et al. “Medicinal chemistry in drug discovery in big pharma: past, present and future”. Drug Discovery Today2 (2018): 219-234.
4. ME Wolff. “Burger’s medicinal chemistry and drug discovery”. American Journal of Therapeutics 8 (1996): 608.
5. B L Claus and D J Underwood. “Discovery informatics: its evolving role in drug discovery”. Drug Discovery Today18 (2002): 957-966.
6. JS Mills and G A Showell. “Exploitation of silicon medicinal chemistry in drug discovery”. Expert Opinion on Investigational Drugs 9 (2004): 1149-1157.
7. L Richter and G F Ecker. “Medicinal chemistry in the era of big data”. Drug Discovery Today: Technologies 14 (2015): 37-41.
8. T Usha., et al. “Recent updates on computer-aided drug discovery: time for a paradigm shift”. Current Topics in Medicinal Chemistry 30 (2018): 3296-3307.
9. GM Cragg., et al. “International collaboration in drug discovery and development: the NCI experience”. Pure and Applied Chemistry 9 (1999): 1619-1633.
10. KR Campos., et al. “The importance of synthetic chemistry in the pharmaceutical industry”. Science (80) (2019): 363.6424.
11. W Sneader. “Drug discovery: a history”. John Wiley and Sons, (2005).
12. G Wu., et al. “Overview of recent strategic advances in medicinal chemistry”. Journal of Medicinal Chemistry 21 (2019): 9375-9414.

Citation

Citation: Abhishek Kumar., et al. “Forced Degradation Studies for Estimation of Finerenone by RP-HPLC Method". Acta Scientific Pharmaceutical Sciences 7.4 (2023): 15-16.

Copyright

Copyright: © 2023 Abhishek Kumar., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.